Then immunohistochemistry analysis demonstrated that CXCR7 expression was significantly higher in tumor masses treated with LMW-HA in contrast to that of control treatment groups (Figure 4(c); Table 2, P = 0.002). This evidence concerns the gene ACKR3 and neoplasm.